The TGF-β family of growth factors is perhaps the primary mediator of fibroblasts, and significant increases in TGF-β levels have been observed in individuals with dilated cardiomyopathy and ischemic cardiomyopathy (Khan, Joyce, Margulies, and Tsuda, 2014). Here, TGFB1 is linked to dilated cardiomyopathy.